Form 8-K - Current report:
SEC Accession No. 0000950170-24-123355
Filing Date
2024-11-07
Accepted
2024-11-07 16:14:14
Documents
12
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20241107.htm   iXBRL 8-K 45504
2 EX-99.1 asmb-ex99_1.htm EX-99.1 237847
  Complete submission text file 0000950170-24-123355.txt   416506

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20241107.xsd EX-101.SCH 30676
14 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20241107_htm.xml XML 4710
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 241435893
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)